Triple-negative breast cancer (TNBC) does not respond to hormone therapies, but we have highly effective treatments available. The standard approach typically combines surgery to remove the tumor, radiation, and chemotherapy. Common chemotherapy drugs include paclitaxel, doxorubicin, and carboplatin. Today, we also successfully use immunotherapy, such as pembrolizumab, to help your immune system fight the cancer. For patients with inherited BRCA gene mutations, targeted medications called PARP inhibitors, like olaparib, are highly useful. Your oncology team will customize this plan specifically for you to ensure the best possible outcome.